Becton, Dickinson and Co (NYSE:BDXB.PFD)
$ 48.16 0.66 (1.39%) Market Cap: - Enterprise Value: - PE Ratio: 48.87 PB Ratio: 2.65 GF Score: 79/100

Becton Dickinson and Co at UBS Global Healthcare Virtual Conference Transcript

May 24, 2021 / 06:00PM GMT
Release Date Price: $54.62 (+0.70%)
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

Okay. Great. Good afternoon, everyone. I'm Matt Taylor, UBS' U.S. Medical Supplies and Devices analyst, and thanks for joining here for our Global Healthcare conference in the afternoon sessions of Day 1. Kicking off this afternoon, we're going to have management from Becton, Dickinson. And I'm really pleased to be joined by Tom Polen, Chairman, CEO and President; Chris Reidy, who's the EVP and CFO. And we also have Kristen Stewart, SVP of Strategy and Investor Relations.

So it seems like there's some background noise going on there. I'm not sure what that is, but if somebody is on the line and not mute, could you please mute your mic.

Thomas E. Polen
Becton, Dickinson and Company - President, CEO & Chairman

We're in our Board room. It's not no here.

Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

I've got

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot